Nestle India issues clarification: Why FMCG stock plunged? What's FSSAI baby formula row; why it matters to consumers?
New Delhi, Sept. 19 -- Nestle India has rejected a recent media report about alleged legal action by the Food Safety and Standards Authority of India (FSSAI) over its baby formula products, calling the report "factually incorrect".
Nestle issued the clarification on September 18, 2026, after receiving a query from the stock exchanges regarding a news report published on Moneycontrol the same day. Nestle India said its products, including NAN Excella Pro and Lactogen Pro, comply with applicable regulations.
"Our products are fully compliant with all the applicable regulations. The said products (i.e., NAN EXCELLA PRO & LACTOGEN PRO) and their labels were approved by the expert committee of FSSAI," it said.
The company further informed t...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.